Mad in America

APRIL 8, 2024

In a recent study , researchers aimed to discover how much of the antidepressant research literature is valid and how much is “hijacked for marketing purposes.” They looked at the largest, most influential clinical trials of antidepressants and found that almost half were so biased that they could be considered “seeding trials”—or studies that provide marketing materials for the pharmaceutical industry, not valid scientific data.

Pharmaceuticals 145

Pharmaceuticals Education 145

Behavioral Health Center of Excellence (BHCOE)

APRIL 10, 2024

Congratulations to our BHCOE Accreditation Members who met the Standards of Excellence in ABA and became accredited in Q4 of 2023 and Q1 of 2024.

52

52

The Anxiety Guy

APRIL 8, 2024

In the latest installment of the Anxiety Guy podcast, I’m excited to unveil an incredibly potent method for journaling your way through anxiety. Tune in, absorb the wisdom, and don’t forget to pass it along to those who could benefit on their journey to overcoming anxiety. Along with today’s journaling for anxiety technique I believe it’s also important to share with you some lessons I personally have come across in relation to journaling.

52

52

Mad in America

APRIL 11, 2024

While harmful physical effects of the use of antipsychotics are often discussed, one crucial adverse effect is often left out: their impact on identity. A new article by Maev Connely from the University College London in the Division of Psychiatry and colleagues argues for increased understanding and discussions of antipsychotics (APs) impact on identity and sense of self.

125

125

Mad in America

APRIL 12, 2024

I arrived at my 18 th birthday 20 pounds overweight, insecure, and foggy, thanks to Depakote and Zyprexa. It was the perfect way to start my senior year of high school. My lovely psychiatrist, Dr. Volls, advised me on the concept of “mood management.” I depended on her expertise to keep me out of crisis, while the medication kept me grounded, sleeping, and helped me forget.

Sleep and mental health 122

Sleep and mental health Nutrition and mood Aging and mental health Trauma and the brain 122

Mad in America

APRIL 6, 2024

Editor’s Note: This article is being simultaneously published on our affiliate site, Mad in the UK. T his is intended as the first part of a look at pathways and outcomes in ‘psychosis’ and ‘schizophrenia’. Here, I discuss some of what’s not right in the picture for the current paradigm; an approach which, in essence, dates from the 1950s. By way of introduction, let’s consider a finding from decades ago.

Early intervention 136

Early intervention Sleep and mental health Manufacturing Healthcare 136

Mad in America

APRIL 9, 2024

T hanks to excellent work of Mark Horowitz and David Taylor we now have the Maudsley Deprescribing Guidelines for Antidepressants, Benzodiazepines, Gabapentinoids, and Z-drugs. I consider this very good news for all who want to taper withdrawal-causing prescription drugs safely, and for all who want to help them as best as they can. The new guidance offers strong and comprehensive support and will aid development of new guidelines and will help to improve existing ones.

Pharmaceuticals 140

Pharmaceuticals Healthcare Education 140